Alocane Plus
- Product NDC
- 68229-300
- 11-digit product format
- 682290300
- Labeler code
- 68229
- Product ID
- 68229-300_3a24dd33-2000-ccc2-e063-6394a90a8f13
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Lidocaine Hydrochloride and Benzalkonium Chloride
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- Quest Products, Inc.
- Application
- M017
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2013-12-11
- Substance
- LIDOCAINE HYDROCHLORIDE; BENZALKONIUM CHLORIDE
- Active strength
- 4; .13 g/100mL; g/100mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 68229-300 | D | Discontinued by firm | 2026-11-19 | ||
| excluded package | package | 68229-300 | 68229-300-02 | D | Discontinued by firm | 2026-11-19 | |
| excluded package | package | 68229-300 | 68229-300-04 | D | Discontinued by firm | 2026-11-19 | |
| excluded package | package | 68229-300 | 68229-300-06 | D | Discontinued by firm | 2026-11-19 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 68229-300-04 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 68229-300-02 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 68229-300-04 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 68229-300-02 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 68229-300-02 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 68229-300-02 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 68229-300-02 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 68229-300-02 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 68229-300-02 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 68229-300-02 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 68229-300-02 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 68229-300-02 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 68229-300-02 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 68229-300-02 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Alocane Plus
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LIDOCAINE HYDROCHLORIDE | 4 g/100mL |
| BENZALKONIUM CHLORIDE | .13 g/100mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V13007Z41A | Internal UNII lookup |
| F5UM2KM3W7 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 24538037-1d74-48a0-b909-98ecc57651fe | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68229-300-02 | 2020-02-03 | C162847 | 48780-1 | 9d75b9d1-2b47-f424-e053-dadaa90a57ce | Alocane ® Plus |
| 68229-300-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-2b47-f424-e053-dadaa90a57ce | Alocane ® Plus |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68229-300-01 | Alocane Plus | 3.55 mL in 1 DOSE PACK | GEL | 3.55 | 10 | |
| 68229-300-02 | Alocane Plus | 50 in 1 BOX | GEL | 50 | 10 | |
| 68229-300-03 | Alocane Plus | 1 in 1 CARTON | GEL | 1 | 10 | |
| 68229-300-03 | Alocane Plus | 59 mL in 1 TUBE | GEL | 59 | 10 | |
| 68229-300-04 | Alocane Plus | 946 mL in 1 BOTTLE, PUMP | GEL | 946 | 10 | |
| 68229-300-05 | Alocane Plus | 3.55 mL in 1 DOSE PACK | GEL | 3.55 | 8 | |
| 68229-300-06 | Alocane Plus | 48 in 1 CARTON | GEL | 48 | 8 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68229-300-01 | EA - Each | 68229-300 | 379cbe87-939f-4066-8e28-789c4c3430db | 1 | 2021-01-08 |
| 68229-300-02 | EA - Each | 68229-300 | b520af95-ef09-4734-9392-dcb3d85fe981 | 1 | 2021-01-08 |
| 68229-300-03 | ML - Milliliter | 68229-300 | 27207190-a638-4f5a-b3df-27cde1c29d3b | 1 | 2021-09-07 |
| 68229-300-04 | ML - Milliliter | 68229-300 | 74748392-6b14-42fc-8c52-9340ed8a8bb3 | 1 | 2021-09-07 |
| 68229-300-05 | ML - Milliliter | 68229-300 | e75b92b2-0797-472a-8c2e-1f676e76b8ff | 2 | 2022-02-07 |
| 68229-300-06 | ML - Milliliter | 68229-300 | 110ad54a-6f0b-4007-9433-4a41ec8d3543 | 2 | 2022-02-07 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68229-300 | ALOCANE PLUS (LIDOCAINE HYDROCHLORIDE AND BENZALKONIUM CHLORIDE) GEL [QUEST PRODUCTS, INC.] | 9 | Current NDC, Legacy NDC, 5 package rows | 20240110_24538037-1d74-48a0-b909-98ecc57651fe.zip |
| 68229-300 | ALOCANE PLUS (LIDOCAINE HYDROCHLORIDE AND BENZALKONIUM CHLORIDE) GEL [QUEST PRODUCTS LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20241107_b3ec09b9-7511-0895-e053-2a95a90a7840.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2587646 | ALOCANE plus 4 % / 0.13 % Topical Gel | PSN | 24538037-1d74-48a0-b909-98ecc57651fe | 10 |
| 2375042 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel | PSN | 24538037-1d74-48a0-b909-98ecc57651fe | 10 |
| 2587646 | benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel [Alocane Plus] | SBD | 24538037-1d74-48a0-b909-98ecc57651fe | 10 |
| 2375042 | benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel | SCD | 24538037-1d74-48a0-b909-98ecc57651fe | 10 |
| 2587646 | Alocane Plus (benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % ) Topical Gel | SY | 24538037-1d74-48a0-b909-98ecc57651fe | 10 |
| 2375042 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel | SY | 24538037-1d74-48a0-b909-98ecc57651fe | 10 |
| 2587646 | ALOCANE plus 4 % / 0.13 % Topical Gel | PSN | b3ec09b9-7511-0895-e053-2a95a90a7840 | 8 |
| 2375042 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel | PSN | b3ec09b9-7511-0895-e053-2a95a90a7840 | 8 |
| 2587646 | benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel [Alocane Plus] | SBD | b3ec09b9-7511-0895-e053-2a95a90a7840 | 8 |
| 2375042 | benzalkonium chloride 0.0013 MG/MG / lidocaine hydrochloride 0.04 MG/MG Topical Gel | SCD | b3ec09b9-7511-0895-e053-2a95a90a7840 | 8 |
| 2587646 | Alocane Plus (benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % ) Topical Gel | SY | b3ec09b9-7511-0895-e053-2a95a90a7840 | 8 |
| 2375042 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 4 % Topical Gel | SY | b3ec09b9-7511-0895-e053-2a95a90a7840 | 8 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68229-300-01 | 68229030001 | 3.55 mL in 1 DOSE PACK | 3.55 ml | Historical | ||||
| 68229-300-02 | 68229030002 | 50 DOSE PACK in 1 BOX (68229-300-02) > 3.55 mL in 1 DOSE PACK (68229-300-01) | 50 dose pack | 2013-12-11 | 0000-00-00 | No | No | Current |
| 68229-300-03 | 68229030003 | 1 TUBE in 1 CARTON (68229-300-03) / 59 mL in 1 TUBE | 1 tube | 2020-03-01 | 0000-00-00 | No | No | Current |
| 68229-300-04 | 68229030004 | 946 mL in 1 BOTTLE, PUMP (68229-300-04) | 946 ml | 2021-07-09 | 0000-00-00 | No | No | Current |
| 68229-300-05 | 68229030005 | 3.55 mL in 1 DOSE PACK | 3.55 ml | Historical | ||||
| 68229-300-06 | 68229030006 | 48 DOSE PACK in 1 CARTON (68229-300-06) > 3.55 mL in 1 DOSE PACK (68229-300-05) | 48 dose pack | 2020-11-12 | 0000-00-00 | No | No | Current |